2020
DOI: 10.1016/j.intimp.2020.106554
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Encapsulated Eugenol by Chitosan Nanoparticles on the aggressive model of rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(15 citation statements)
references
References 25 publications
0
14
0
1
Order By: Relevance
“…As mentioned before, TNF-α induces impaired function of Treg cells via FOXP3 and inhibits their protective role in the synovium, while TNF receptor type II (TNFRII), the receptor type that mediated the anti-inflammatory effects of TNF, has been demonstrated to participate in maintaining the stable expression of FOXP3, suggesting that the potential mechanism of anti-TNF agent in RA treatment may be attributed to the expansion of TNFRII + Treg cells (Santinon et al, 2020). Moreover, because oxidative stress and RA are closely related pathologically, antioxidant therapy has also been considered as a prospective strategy of RA (Khojah et al, 2016;Jabbari et al, 2020). In addition, the Hippo-Yes-associated protein (YAP) signaling pathway regulates the expression of target genes to affect a series of physiological activities through responding to other intracellular and extracellular signals, consequently playing important roles in cell proliferation, differentiation, and apoptosis, which suggests its indispensable impacts on osteogenesis and immune regulation (Liu et al, 2016;Xiang et al, 2018;Wang et al, 2019).…”
Section: Rheumatoid Arthritismentioning
confidence: 99%
“…As mentioned before, TNF-α induces impaired function of Treg cells via FOXP3 and inhibits their protective role in the synovium, while TNF receptor type II (TNFRII), the receptor type that mediated the anti-inflammatory effects of TNF, has been demonstrated to participate in maintaining the stable expression of FOXP3, suggesting that the potential mechanism of anti-TNF agent in RA treatment may be attributed to the expansion of TNFRII + Treg cells (Santinon et al, 2020). Moreover, because oxidative stress and RA are closely related pathologically, antioxidant therapy has also been considered as a prospective strategy of RA (Khojah et al, 2016;Jabbari et al, 2020). In addition, the Hippo-Yes-associated protein (YAP) signaling pathway regulates the expression of target genes to affect a series of physiological activities through responding to other intracellular and extracellular signals, consequently playing important roles in cell proliferation, differentiation, and apoptosis, which suggests its indispensable impacts on osteogenesis and immune regulation (Liu et al, 2016;Xiang et al, 2018;Wang et al, 2019).…”
Section: Rheumatoid Arthritismentioning
confidence: 99%
“…Jabbari and colleagues investigated the effects of encapsulated eugenol with chitosan nanoparticles on a neonatal CIA-rat model [81]. Eugenol-entrapped chitosan nanoparticles (Eug-CNPs) were prepared through the solvent dispersion method, and evaluated for anti-oxidative stress (malondialdehyde for assessment of lipid peroxidation) by an assay kit, FOXO3 protein as an antioxidant up-regulating by western blotting, and expression of the TGF-β and CCL2/MCP-1 genes by real-time PCR evaluation, supported by a cartilage histopathology analysis.…”
Section: Nano-formulation Of Isolated Compoundsmentioning
confidence: 99%
“…Sodium alginate has been used to prepare Ibuprofen microbeads with a variety of physicochemical properties [147]. Encapsulated Eugenol with Chitosan Nanoparticle has been able to alleviate the symptoms of joint inflammation, synovial hyperplasia, and cartilage damage caused by RA in rats ( Figure 5) [148]. Chitosan improved Leflunomide's anti-arthritic effect when used as a coating in an oral nanosystem in an RA-induced rat model.…”
Section: Advantages and Applications Of Various Marine-derived Compoumentioning
confidence: 99%
“…Evaluation of Encapsulated Eugenol by Chitosan Nanoparticles on the aggressive model of rheumatoid arthritis. Reprinted from[148] with permission from Elsevier. © 2020 Elsevier B.V.…”
mentioning
confidence: 99%